Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 09255710 AND DT 2014 AND VI 99 AND IP 1
Results: 16
1
2
Focal 18F-FDG uptake in bone marrow on PET/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation.
- Published in:
- 2014
- By:
- Publication type:
- Report
4
Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity.
- Published in:
- 2014
- By:
- Publication type:
- Report
5
Expression of different functional isoforms in haematopoiesis.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 4, doi. 10.1007/s12185-013-1477-7
- By:
- Publication type:
- Article
6
Focal F-FDG uptake in bone marrow on PET/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm.
- Published in:
- 2014
- By:
- Publication type:
- Letter
7
Validation of a new proposed relapse risk score (CBC-score) for acute promyelocytic leukaemia.
- Published in:
- 2014
- By:
- Publication type:
- Letter
8
Distribution of serum erythropoietin levels in lower risk myelodysplastic syndrome cases with anemia.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 53, doi. 10.1007/s12185-013-1485-7
- By:
- Publication type:
- Article
9
High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 69, doi. 10.1007/s12185-013-1465-y
- By:
- Publication type:
- Article
10
Hepcidin production in response to iron is controlled by monocyte-derived humoral factors.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 12, doi. 10.1007/s12185-013-1476-8
- By:
- Publication type:
- Article
11
Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 79, doi. 10.1007/s12185-013-1472-z
- By:
- Publication type:
- Article
12
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 41, doi. 10.1007/s12185-013-1483-9
- By:
- Publication type:
- Article
13
A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 57, doi. 10.1007/s12185-013-1484-8
- By:
- Publication type:
- Article
14
Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 21, doi. 10.1007/s12185-013-1466-x
- By:
- Publication type:
- Article
15
Chronic myeloid leukemia patient with co-occurrence of BCR- ABL junction and JAK2 V617F mutation.
- Published in:
- 2014
- By:
- Publication type:
- Report
16
JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 32, doi. 10.1007/s12185-013-1475-9
- By:
- Publication type:
- Article